Skip to Main Content
Status Submitted
Workspace * IBM Cloud Ideas
Categories Compliance
Created by Guest
Created on Nov 22, 2026

Pulsed Field Ablation Treatment Record Standard

PROBLEM: Pulsed field ablation is now FDA-approved for atrial fibrillation across multiple systems, but treatment records vary, making it hard to compare outcomes, energy doses, and recurrence across sites.

SOLUTION: A standard treatment record for every PFA procedure: system used, energy parameters, lesion set, acute success, complications, and recurrence at follow-up, recorded in a common format so outcomes can be compared across the approved systems.

EVIDENCE BASIS: DOCUMENTED — Abbott Volt PFA FDA approved Dec 22, 2025 (VOLT-AF IDE, 392 patients); Boston Scientific FARAPULSE expanded labeling July 7, 2025 (ADVANTAGE AF, 260 patients, 85.3% symptomatic recurrence-free); Medtronic PulseSelect FDA approved Dec 2023. Research note D6, D7, D8.

Idea priority Low
Needed By Not sure -- Just thought it was cool